Search results
FDA accepts filing of Leqembi® (lecanemab-irmb) sBLA for IV maintenance dosing for the treatment of...
Benzinga· 4 days agoBioArctic AB's (publ) (NASDAQ Stockholm: BIOA B) partner Eisai announced today that that the U.S. Food and Drug Administration (FDA) has accepted Eisai's Supplemental Biologics ...
EMEA Morning Briefing: Markets Brace for Double Header of U.S. CPI, Fed Decision
Morningstar· 2 days agoMARKET WRAPS Watch For: Germany CPI; UK monthly GDP estimates, trade, industrial production; no major corporate events expected Opening Call: European stock futures rose as U.S. CPI and the Fed decision due later today keep traders
UC Berkeley’s legal victory allows People’s Park housing project to proceed — for now
Los Angeles Times· 7 days agoA decades-long land-use saga in Berkeley has (maybe) finally reached its conclusion. The California...
FDA accepts filing of Leqembi® (lecanemab-irmb) sBLA for IV maintenance dosing for the treatment of...
KSAN - KLST San Angelo· 4 days agoBioArctic AB's (publ) (NASDAQ Stockholm: BIOA B) partner Eisai announced today that that the U.S. Food and Drug Administration (FDA) has accepted Eisai's Supplemental Biologics ...